Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengui capsule is a traditional Chinese medicine (TCM) herbal compound formulation used primarily for the treatment of heart failure, particularly chronic heart failure. It contains multiple active ingredients derived from various medicinal herbs. The mechanism of action is not fully elucidated but network pharmacology and molecular docking studies suggest that its therapeutic effects are related to modulation of inflammatory pathways—specifically through interaction with interleukin-1β (IL-1β)—and other targets involved in cardiovascular health. Clinical studies indicate that when combined with conventional heart failure therapy, Shengui capsule can improve left ventricular ejection fraction (LVEF) and overall clinical effectiveness in patients with chronic heart failure. Safety data suggest few side effects over short-term use; however, further high-quality studies are needed to fully establish its safety profile[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shengui capsule.